Omniome Competitors, Revenue, Alternatives and Pricing

Claim your profile

Overview

Location:
Total Funding:$100.2M
Industry:Biotech
Founded:2013
Lead Investor(s):Decheng Capital, Hillhouse Capital Group

City Ranking

Industry Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • Omniome's estimated annual revenue is currently $22.6M per year.
  • Omniome received $60.0M in venture funding in July 2018.
  • Omniome's estimated revenue per employee is $155,000
  • Omniome's total funding is $100.2M.

Employee Data

  • Omniome has 146 Employees.
  • Omniome grew their employee count by 36% last year.
  • Omniome currently has 10 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
DiaCarta
$7M4510%N/A-N/A
Geron Corporati...
N/A205N/AN/A-N/A
Rigel Pharmaceu...
$46.8M3024%N/A-N/A
Althea Technolo...
$22.3M144N/AN/A-N/A
INOVA Diagnosti...
$44.3M286N/AN/A-N/A
10X Genomics
$101.2M65346%N/A-N/A
ProTrials Resea...
$33.3M2153%N/A-N/A
Advanced Cell D...
$28.7M1858%N/A-N/A
The J. Craig Ve...
$39.4M254N/AN/A-N/A
CellMax Life
$6.5M4214%N/A-N/A
Missing a competitor? Contribute!?
Submit

Based in San Diego and founded in 2013, Omniome is a biotechnology company developing a breakthrough DNA sequencing platform that delivers highly accurate and fast results at low cost with the potential to advance cancer diagnostics, drive high fidelity single-cell applications and broadly support clinical sequencing. Our scar-free, Sequencing By Binding (SBB) technology provides enhanced precision of nucleotide and DNA matching by leveraging the natural matching ability of the polymerase, decreasing runtimes and increasing the number of samples per run. We offer a stimulating, fast-paced, start-up work environment where innovative and highly-motivated team players will thrive.

keywords:N/A

146

Number of Employees

$22.6M

Revenue (est)

10

Current Jobs

36%

Employee Growth %

$100.2M

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

Omniome News

09/03/2019 - TTAB Posts September 2019 Hearing Schedule - Intellectual ...

September 12, 2019 - 11 AM: In re Omniome, Inc., Serial No. 87661190 [Section 2(e)(1) mere descriptiveness refusal of SEQUENCING BY ...

07/30/2018 - Omniome Completes $60 Million Series B Financing To ...

SAN DIEGO, July 30, 2018 /PRNewswire/ -- Omniome, Inc., developer of an innovative new DNA sequencing platform, today announced it has ...

09/03/2019 - Life Science Fuels Growth in San Diego's Office Market

Biotech firm Omniome recently leased more than 74,000 square feet in this Sorrento Mesa office property, where renovations are currently ...

Omniome Funding

DateAmountRoundLead InvestorsReference
2018-07-31$60.0MBDecheng CapitalArticle